Evidence map›Paper›PMID 32400965›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2020

Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.

Tian Xia, Yanfeng Wang

Abstract readLetterComment
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. COVID-19 in Children With Liver Disease.Frontiers in pediatrics · 2021
    Review
  8. Article
  9. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature.Current treatment options in infectious diseases · 2021
    Review
  10. Article
  11. Kidney transplant recipients infected by COVID-19: Review of the initial published experience.Transplant infectious disease : an official journal of the Transplantation Society · 2020
    Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Tian XiaZhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Yanfeng WangZhongnan Hospital of Wuhan University, Wuhan, Hubei, China.ORCID 0000-0002-3859-0937

Funding

National Natural Science Foundation of China 81570079
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusCOVID-19COVID-19 Drug TreatmentHumansHydroxychloroquineLopinavirRitonavirSARS-CoV-2SpainTacrolimusTransplant RecipientsHydroxychloroquineLopinavirRitonavirTacrolimusantibiotic: antiviralclinical research/practicecomplication: infectiousdrug interactioninfectious diseasekidney transplantation/nephrologyliver transplantation/hepatology

Identifiers

PMID32400965
PMCPMC7273014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.